Regulation of human renin and angiotensinogen genes. 1991

A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
Institute of Applied Biochemistry, University of Tsukuba, Ibaraki, Japan.

We have constructed pUCSV0cat with low background of chloramphenicol acetyltransferase (CAT) activity and pUCSV3cat (positive control), both containing a SV40 polyadenylation signal 5' to the CAT-coding gene and to the SV40 promoter, respectively. Using this modified pUCSV0cat, we found that human embryonic 293 cells have the ability to activate the promoter of the human renin gene. In addition, we identified the cis-acting sequences responsible for cell-specific expression of the human angiotensinogen gene in its 5'-flanking region.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000808 Angiotensinogen An alpha-globulin of about 453 amino acids, depending on the species. It is produced by the liver in response to lowered blood pressure and secreted into blood circulation. Angiotensinogen is the inactive precursor of the ANGIOTENSINS produced in the body by successive enzyme cleavages. Cleavage of angiotensinogen by RENIN yields the decapeptide ANGIOTENSIN I. Further cleavage of angiotensin I (by ANGIOTENSIN CONVERTING ENZYME) yields the potent vasoconstrictor octapeptide ANGIOTENSIN II; and then, via other enzymes, other angiotensins also involved in the hemodynamic-regulating RENIN-ANGIOTENSIN SYSTEM. Hypertensinogen,Renin-Substrate,SERPINA8,Proangiotensin,Renin Substrate Tetradecapeptide,Serpin A8,Renin Substrate,Tetradecapeptide, Renin Substrate
D015500 Chloramphenicol O-Acetyltransferase An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28. CAT Enzyme,Chloramphenicol Acetyltransferase,Chloramphenicol Transacetylase,Acetyltransferase, Chloramphenicol,Chloramphenicol O Acetyltransferase,Enzyme, CAT,O-Acetyltransferase, Chloramphenicol,Transacetylase, Chloramphenicol

Related Publications

A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
January 1991, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
December 1987, Endocrinologia japonica,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
January 1999, Hypertension (Dallas, Tex. : 1979),
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
March 1997, The Journal of clinical investigation,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
February 2000, Hypertension (Dallas, Tex. : 1979),
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
November 2010, PloS one,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
December 1995, Clinical and experimental pharmacology & physiology. Supplement,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
February 2009, Stroke,
A Fukamizu, and K Tanimoto, and S Uehara, and M S Seo, and S Handa, and M Sagara, and S Takahashi, and T Imai, and K Murakami
December 1998, Journal of the American Society of Nephrology : JASN,
Copied contents to your clipboard!